226 related articles for article (PubMed ID: 10609794)
21. The presence and subtype of Epstein-Barr virus in B and T cell lymphomas of the sino-nasal region from the Osaka and Okinawa districts of Japan.
Tomita Y; Ohsawa M; Mishiro Y; Kubo T; Maeshiro N; Kojya S; Noda Y; Aozasa K
Lab Invest; 1995 Aug; 73(2):190-6. PubMed ID: 7637319
[TBL] [Abstract][Full Text] [Related]
22. Nasal T/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage.
Chiang AK; Chan AC; Srivastava G; Ho FC
Int J Cancer; 1997 Nov; 73(3):332-8. PubMed ID: 9359478
[TBL] [Abstract][Full Text] [Related]
23. Determination of frequency of epstein-barr virus in non- Hodgkin lymphomas Using EBV latent membrane protein 1 (EBV-LMP1) immunohistochemical staining.
Ishtiaq S; Hassan U; Mushtaq S; Akhtar N
Asian Pac J Cancer Prev; 2013; 14(6):3963-7. PubMed ID: 23886215
[TBL] [Abstract][Full Text] [Related]
24. High frequency of Epstein Barr virus latent membrane protein-1 30 bp deletion in a series of pediatric malignancies in Argentina.
Chabay P; De Matteo E; Merediz A; Preciado MV
Arch Virol; 2004 Aug; 149(8):1515-26. PubMed ID: 15290377
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus genome in non-Hodgkin's lymphomas occurring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Danish Lymphoma Study Group, LYFO.
d'Amore F; Johansen P; Houmand A; Weisenburger DD; Mortensen LS
Blood; 1996 Feb; 87(3):1045-55. PubMed ID: 8562929
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of EBV RNA in sinonasal and Waldeyer's ring lymphomas.
Lee JH; Lee SS; Park JH; Kim YW; Yang MH
J Korean Med Sci; 1994 Aug; 9(4):281-8. PubMed ID: 7848575
[TBL] [Abstract][Full Text] [Related]
27. Genotypic and phenotypic alterations in Epstein-Barr virus-associated lymphoma.
Ohshima K; Suzumiya J; Kanda M; Haraoka S; Kawasaki C; Shimazaki K; Kikuchi M
Histopathology; 1999 Dec; 35(6):539-50. PubMed ID: 10583578
[TBL] [Abstract][Full Text] [Related]
28. Genomic analysis of Epstein-Barr virus in nasal and peripheral T-cell lymphoma: a comparison with nasopharyngeal carcinoma in an endemic area.
Wu SJ; Lay JD; Chen CL; Chen JY; Liu MY; Su IJ
J Med Virol; 1996 Dec; 50(4):314-21. PubMed ID: 8950688
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus in lymphoproliferative diseases in the sino-nasal region: close association with CD56+ immunophenotype and polymorphic-reticulosis morphology.
Tomita Y; Ohsawa M; Qiu K; Hashimoto M; Yang WI; Kim GE; Aozasa K
Int J Cancer; 1997 Jan; 70(1):9-13. PubMed ID: 8985084
[TBL] [Abstract][Full Text] [Related]
30. Characteristics of Epstein-Barr virus associated childhood non-Hodgkin's lymphoma in the Republic of Korea.
Kim D; Ko Y; Suh Y; Koo H; Huh J; Lee W
Virchows Arch; 2005 Sep; 447(3):593-6. PubMed ID: 15991005
[TBL] [Abstract][Full Text] [Related]
31. [Nasal and pharyngeal non-Hodgkin lymphomas and their relationship with Epstein-Barr virus: a report of 158 cases].
He YJ; Jia XS; Hasui K; Wang EH; He AG
Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):94-7. PubMed ID: 17493382
[TBL] [Abstract][Full Text] [Related]
32. Characterization of a novel human natural killer-cell line (NK-YS) established from natural killer cell lymphoma/leukemia associated with Epstein-Barr virus infection.
Tsuchiyama J; Yoshino T; Mori M; Kondoh E; Oka T; Akagi T; Hiraki A; Nakayama H; Shibuya A; Ma Y; Kawabata T; Okada S; Harada M
Blood; 1998 Aug; 92(4):1374-83. PubMed ID: 9694726
[TBL] [Abstract][Full Text] [Related]
33. EBV-NK cells interactions and lymphoproliferative disorders.
Kanegane H; Yachie A; Miyawaki T; Tosato G
Leuk Lymphoma; 1998 May; 29(5-6):491-8. PubMed ID: 9643562
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of Epstein-Barr virus associated with nasal lymphoma in patients attending the regional hospital of Valdivia, Chile, between 1987 and 2005.
Martin C; Carrasco C; Sotomayor C; Otth C
J Med Virol; 2010 May; 82(5):825-8. PubMed ID: 20336747
[TBL] [Abstract][Full Text] [Related]
35. Epstein-barr virus (EBV) in healthy carriers: Distribution of genotypes and 30 bp deletion in latent membrane protein-1 (LMP-1) oncogene.
Correa RM; Fellner MD; Alonio LV; Durand K; Teyssié AR; Picconi MA
J Med Virol; 2004 Aug; 73(4):583-8. PubMed ID: 15221903
[TBL] [Abstract][Full Text] [Related]
36. Nasopharyngeal/nasal type T/NK lymphomas: analysis of 14 cases and review of the literature.
García-Cosío M; Santón A; Méndez MC; Rivas C; Martín C; Bellas C
Tumori; 2003; 89(3):278-84. PubMed ID: 12908783
[TBL] [Abstract][Full Text] [Related]
37. Histological and immunophenotypic profile of nasal NK/T cell lymphomas from Peru: high prevalence of p53 overexpression.
Quintanilla-Martinez L; Franklin JL; Guerrero I; Krenacs L; Naresh KN; Rama-Rao C; Bhatia K; Raffeld M; Magrath IT
Hum Pathol; 1999 Jul; 30(7):849-55. PubMed ID: 10414505
[TBL] [Abstract][Full Text] [Related]
38. Comparative analysis of Epstein-Barr virus gene polymorphisms in nasal T/NK-cell lymphomas and normal nasal tissues: implications on virus strain selection in malignancy.
Chiang AK; Wong KY; Liang AC; Srivastava G
Int J Cancer; 1999 Jan; 80(3):356-64. PubMed ID: 9935174
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus infection in the neoplastic and nonneoplastic cells of lymphoid malignancies.
Teramoto N; Sarker AB; Tonoyama Y; Yoshino T; Hayashi K; Takahashi K; Akagi T
Cancer; 1996 Jun; 77(11):2339-47. PubMed ID: 8635105
[TBL] [Abstract][Full Text] [Related]
40. Post-transplantation lymphoproliferative disorders in Mexico: an aggressive clonal disease associated with Epstein-Barr virus type A.
Quintanilla-Martínez L; Lome-Maldonado C; Schwarzmann F; Gredler E; Reyes E; Angeles-Angeles A; Fend F
Mod Pathol; 1998 Feb; 11(2):200-8. PubMed ID: 9504692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
